Patient characteristics | All patients in the Alberta EMR Database, n (%) | Patients with Cannabis use recorded in their EMR, n (%) | P-Value | ||
---|---|---|---|---|---|
Females N = 212 819 | Males N = 185 711 | Females N = 1 990 | Males N = 2 661 | ||
Age group in years | p < 0.001 | ||||
 Under 10 | 21 349 (10.0) | 23 544 (12.7) | 5 (0.3) | 7 (0.3) |  |
 10–19 | 22 265 (10.5) | 21 579 (11.6) | 68 (3.4) | 88 (3.3) |  |
 20–29 | 26 004 (12.2) | 19 902 (10.7) | 380 (19.1) | 483 (18.2) |  |
 30–39 | 33 669 (15.8) | 24 555 (13.2) | 389 (19.5) | 493 (18.5) |  |
 40–49 | 28 026 (13.2) | 24 643 (13.3) | 322 (16.2) | 442 (16.6) |  |
 50–59 | 28 252 (13.3) | 25 597 (13.8) | 390 (19.6) | 544 (20.4) |  |
 60–69 | 24 993 (11.7) | 23 247 (12.5) | 257 (12.9) | 426 (16.0) |  |
 70 and older | 28 261 (13.3) | 22 644 (12.2) | 179 (9.0) | 178 (6.7) |  |
Residence location | p < 0.001 | ||||
 Rural | 37 812 (17.8) | 33 514 (18.0) | 377 (18.9) | 395 (14.8) |  |
 Urban | 167 246 (78.6) | 144 230 (77.7) | 1 501 (75.4) | 2 028 (76.2) |  |
 Missing postal code | 7 761 (3.6) | 7 967 (4.3) | 112 (5.6) | 238 (8.9) |  |
Presence of chronic conditions as defined by CPCSSN algorithms | |||||
 CKD | 9 450 (4.4) | 6 752 (3.6) | 132 (6.6) | 87 (3.3) | p < 0.001 |
 COPD | 6 999 (3.3) | 7 735 (4.2) | 206 (10.4) | 382 (14.4) | p < 0.001 |
 Depression | 51 368 (24.1) | 27 695 (14.9) | 1315 (66.1) | 1350 (50.7) | p < 0.001 |
 Diabetes mellitus | 15 564 (7.3) | 16 468 (8.9) | 267 (13.4) | 289 (10.9) | p < 0.001 |
 Epilepsy | 2 664 (1.3) | 2 635 (1.4) | 83 (4.2) | 120 (4.5) | p < 0.001 |
 Hypertension | 38 374 (18.0) | 35 441 (19.1) | 534 (26.8) | 652 (24.5) | p < 0.001 |
 Osteoarthritis | 24 602 (11.6) | 17 058 (9.2) | 453 (22.8) | 482 (18.1) | p < 0.001 |
 Parkinson’s disease | 477 (0.2) | 622 (0.3) | 9 (0.5) | 22 (0.8) | p < 0.001 |
 Pediatric asthma | 8 990 (4.2) | 10 538 (5.7) | 70 (3.5) | 77 (2.9) | p < 0.001 |
 Nonea | 112 299 (52.8) | 103 876 (55.9) | 384 (19.3) | 720 (27.1) | p < 0.001 |